Today is an exciting day time for Allergan and our 30 more.

The company name change follows the acquisition of Allergan in March 2015 and the acceptance of the name switch by Actavis shareholders on June 5. Today is an exciting day time for Allergan and our 30,000 employees all over the world who have helped us reach this particular moment, said Brent Saunders, President and CEO of Allergan. Today, under a single company name and identity, we lay out on a new path ahead, encouraging our employees around the world to become bold in how exactly we think and action, to engage also to move quickly to meet the needs of physicians, patients and customers more . Related StoriesGenetic carrier screening: an interview with Don Hardison, CEO of Great Start GeneticsHealthcare technology public event of the entire year opens entriesRE.Function showcases future technology and improvements in deep learning software Allergan is home to world-renowned brands, the best-in-course global generics business, a premier pharmaceutical pipeline of medicines including brands, generics, biosimilars, OTC devices and products, and also the fourth largest distributor in the U.S., that may retain the true name Anda.